Cetera Investment Advisers’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Cetera Investment Advisers's RMD Position: Q2 2026 in Review
Cetera Investment Advisers reduced its ResMed (RMD) stake by 1.6% in Q2 2026, selling an estimated $51.4K and leaving 15,436 shares worth $3.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2040.
Cetera Investment Advisers first reported a position in RMD in Q2 2020 and has held it in 21 quarters since. The position peaked at $4.25M in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Cetera Investment Advisers held 15,436 shares of ResMed worth $3.01M as of Q2 2026.
- Cetera Investment Advisers sold 248 ResMed shares in Q2 2026, an estimated $51.4K.
- ResMed made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2040 holding.
- Cetera Investment Advisers first reported a position in ResMed in Q2 2020 and has held it in 21 quarters since.
- Cetera Investment Advisers's ResMed position peaked at $4.25M in Q3 2025.
- 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.